Healthcare utilisation, morbidities and alcohol use monitoring prior to alcoholic psychosis diagnosis by Otete, Harmony et al.
1 
 
Healthcare utilisation, morbidities and alcohol use monitoring prior 
to alcoholic psychosis diagnosis. 
Otete Harmony, Assistant Professor1,2 
Fleming M Kate, Associate Professor3 
West Joe, Professor1 
Orton Elizabeth, Associate Professor4 
 
Affiliations 
1 Division of Epidemiology and Public health, School of Medicine, University of Nottingham, 
City Hospital Campus, Nottingham, NG5 1PB, United Kingdom. 
2 School of Medicine, University of Central Lancashire, Preston, PR1 2HE, United Kingdom 
3 Department of Public health and Policy, University of Liverpool, Liverpool, L69 3GB, United 
Kingdom. 
4 Division of Primary care, School of Medicine, University of Nottingham, University Park, 
Nottingham, NG7 2RD, United kingdom. 
 
Correspondence to: Harmony E Otete, Email: hotete@uclan.ac.uk 
 
Declaration of interest: There are no conflicts of interest to declare for any of the 
authors.  
 
 
 
 
 
2 
 
Abstract 
Aims: This study aimed to describe healthcare utilisation, morbidities and monitoring of 
alcohol use in patients prior to a diagnosis of alcoholic psychosis in order to inform the early 
identification of patients at risk. 
Method: Using linked general practice and hospitalisation data in England (April 1997 to 
June 2014) we identified 1,731 individuals (≥ 18 years) with a clinical recorded diagnosis of 
alcoholic psychosis and 17,310 matched controls without the disorder. We examined all prior 
general practitioner (family doctor) visits, hospitalisations, medically-recorded morbidities, 
alcohol assessment/interventions records. Poisson regression models were used to 
compare rates of healthcare utilisation in people with alcoholic psychosis to those without. 
Logistic regression models were used to evaluate the association between alcoholic 
psychosis and prior morbidities.  
Results: Patients with alcoholic psychosis showed increased levels of healthcare utilisation 
at least 5 years prior to their diagnosis. The most common reasons for prior healthcare visits 
were seizures and injuries and there was more than 4-fold higher rate of seizures, 
unintentional injuries and self-harm incidents among these patients up to 10 years prior to 
diagnosis, compared to the control population.  A high proportion (78%) of patients had their 
alcohol consumption recorded, 50% had a record of heavy drinking but only 1 in 5 had any 
evidence of receiving an alcohol-related intervention.  
Conclusion: Patients present more often with seizures and injuries than the general 
population several years prior to a diagnosis of alcoholic psychosis. These visits represent 
opportunities for preventive action and imply that we may be missing opportunities to 
intervene. 
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Summary 
 
Several years prior to a diagnosis of alcoholic psychosis, patients present more often with 
seizures and injuries (falls, fractures, assaults and self-harm) than the general population. 
Targeting interventions at such patients could be a more sensitive way of identifying heavy 
drinkers that are more likely to develop alcoholic psychosis.  
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Introduction 
Alcoholic psychosis is a mental and behavioural disorder resulting from chronic alcoholism 
(1). Although distinct from Schizophrenia, the core features of the syndrome include 
delusions; hallucinations, usually in the form of derogatory and threatening voices; mood 
disorders, impaired thought process and inappropriate behaviour (2). The lifetime prevalence 
of alcoholic psychosis has been estimated to approximate 0.5%-1.8% (3,4). However, in 
individuals who develop the disorder, there are serious health risks including an increased 
risk of suicidal behaviour with or without depression, and a rehospitalisation rate of up to 
60% (2-5). Mental and behavioural disorders due to alcohol use accounted for over 200,000 
hospital admissions in 2012 in the UK and remain among the top three causes of alcohol 
related morbidity in the UK (6). Currently, there is no evidence-based treatment available for 
Alcoholic psychosis and so preventing chronic alcohol use in the first place is the main 
option currently for interrupting the pathway leading to the disease. 
Extensive evidence both in the UK and globally show that alcohol screening and brief 
interventions can effectively interrupt the course of alcohol harm by first, identifying people 
who consume alcohol at levels that put their health at risk, and motivating a positive change 
in drinking behaviour to lower risk levels (7-10). The use of alcohol screening combined with 
information on early indicators of alcohol psychosis could aid earlier identification and better 
targeting of at-risk individuals, if these indicators are known by practitioners. However, to 
date, there is limited research into the pathway leading to a diagnosis of alcoholic psychosis. 
More specifically, there are very few published studies describing healthcare utilisation prior 
to alcoholic psychosis with even fewer studies describing what patients present with prior to 
the disease. 
With access to linked primary care and hospitalisation data in the UK, there is an opportunity 
to study healthcare use and the clinical trajectory leading up to a diagnosis with alcoholic 
psychosis in order to inform early detection and prevention strategies. We have therefore 
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carried out a retrospective study on individuals diagnosed with alcoholic psychosis using 
these linked data. We specifically aimed to describe patterns of help-seeking in primary and 
secondary care and to identify the other alcohol related morbidities patient present with prior 
to diagnosis of alcoholic psychosis. To understand the current practice relating to alcohol 
interventions and to further inform alcohol harm preventive strategies, we quantified the 
number of patients who received an alcohol assessment or alcohol brief intervention prior to 
alcoholic psychosis diagnosis. 
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Methods 
The linked primary care and hospitalisation data were obtained from the Clinical Practice 
Research datalink(CPRD) and Hospital Episodes Statistics(HES) respectively. 
General Practitioners (family doctors) in the UK are the gatekeepers of most types of 
secondary healthcare and nearly 98% of the total UK population are registered with a 
general practice. The CPRD database holds medical records from over 600 UK general 
practices serving approximately 6% of the total UK population and is nationally 
representative (11). Data recorded within the CPRD include patient demography, clinical 
diagnoses coded using Read codes (based on the International Classification of Diseases 
version 10 ICD-10), patient prescriptions, test results, behavioural habits such as alcohol use 
and smoking status, and behavioural interventions. These data are recorded prospectively 
by General Practitioners during primary care consultations or following correspondence 
regarding secondary care treatment, and have been extensively validated for research 
purposes (12).   
More than 50% of the patients in CPRD are linkable to hospitalisation data which is held 
within the Hospital Episodes Statistics (HES) database. HES captures information on all 
inpatient hospital admissions in England and includes hospital diagnoses coded using the 
ICD-10. For this study, we restricted our source population to only those patients that are 
linkable across CPRD and HES to allow us obtain a comprehensive history of the health 
service utilisation of each patient. Linked hospitalisation data were available from 1997 to 
2014. Approval for use of these linked data was given by the Scientific and Ethical 
Committee of the CPRD (15_073RAR). 
Study population 
Using a list of Read and ICD 10 diagnostic codes, we identified all patients with a diagnosis 
of alcoholic psychosis between April 1997 and June 2014.  To avoid being restrictive, we 
also included patients with other alcohol-related syndromes associated with psychotic 
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features such as alcoholic paranoia, alcoholic dementia, and alcoholic hallucinosis. Table 1 
shows the list of Read and ICD-10 diagnosis codes used. 
Table 1: Read and ICD 10 diagnosis used for identifying study population 
Codes  Diagnosis 
ICD 10  
F10.5 
F10.7 
F10.8 
F10.9 
Mental and behavioural disorders due to use of alcohol, psychotic disorder 
Mental and behavioural disorders due to use of alcohol, residual and late-onset 
psychotic disorder 
Mental and behavioural disorders due to use of alcohol, other mental and 
behavioural disorders 
Mental and behavioural disorders due to use of alcohol, unspecified mental and 
behavioural disorder 
Read Codes  
Eu10513 
E011000 
E015.00 
Eu10514 
E011100 
E01z.00 
Eu10711 
E01y.00 
Eu10511 
E01..00 
E01yz00 
1B1c.00 
Eu10500 
E011200 
Eu10611 
E012.00 
Alcoholic paranoia 
Korsakov's alcoholic psychosis 
Alcoholic paranoia 
Alcoholic psychosis NOS 
Korsakov's alcoholic psychosis with peripheral neuritis 
Alcoholic psychosis NOS 
Alcoholic dementia NOS 
Other alcoholic psychosis 
Alcoholic hallucinosis 
Alcoholic psychoses 
Other alcoholic psychosis NOS 
Alcohol induced hallucinations 
Mental & behavioural disorder due to use alcohol: psychotic disorder 
Wernicke-Korsakov syndrome 
Korsakov's psychosis, alcohol induced 
Other alcoholic dementia 
 
Each identified patient was assigned an index date of diagnosis which was the date of the 
first record of any of the above conditions in either their primary care (CPRD) or secondary 
care(HES) record.  We excluded patients whose diagnosis date fell within 1 year of 
registration with a general practice (to exclude prevalent cases) or patients with invalid or 
missing diagnosis dates. Further exclusions were patients less than 18 years old at 
diagnosis, patients flagged as unacceptable for research as per CPRD quality rules (which is 
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usually an indicator of patients with incomplete/inconsistent follow-up data), and those 
diagnosed outside the up-to-research-standard time periods as per CPRD quality rules. 
 
Comparison group 
For each identified patient, we selected up to 10 general population controls matched by 
general practice, sex and age (within 5 years). Each identified control was assigned an index 
date, which was a randomly generated date from 1 year after the start of the linked dataset 
(1997) up to the date they left their general practice or died. We excluded controls who had 
prior history of any type of psychosis before their pseudo-diagnosis date; this allowed the 
exclusion of patients with psychosis that may be alcohol related but are not recorded as 
such. 
 
Outcome measures 
Healthcare utilisation 
Our assessment of healthcare utilisation was as we have previously reported (13). Briefly, 
we extracted data on all primary care consultations and in-patient hospitalisations prior to the 
index date for the alcoholic psychosis cohort and for the comparison group.  
Prior morbidities of interest 
Morbidities assessed are those known to be associated with alcohol use which could 
potentially serve as indicators of alcohol harm. Public Health England has produced a 
national guide on alcohol-attributable burden which contains a summary of these 
morbidities(6). The guide, which has been validated against other international sources, 
includes over 30 different morbidities broadly categorised in two groups: 1) alcohol specific 
conditions (alcoholic liver damage, alcohol-induced pseudo-cushing's syndrome, accidental 
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poisoning by methanol or ethanol, alcoholic cardiomyopathy, alcohol-induced chronic 
pancreatitis, alcoholic gastritis, acute alcoholic intoxication, alcoholic myopathy, cerebral 
degeneration due to alcoholism, alcoholic encephalopathy, alcoholic polyneuropathy) and 2) 
alcohol related conditions (oral cancers, oesophageal cancer , colorectal cancer, breast 
cancer, diabetes mellitus, epilepsy, hypertensive disease, ischaemic heart disease, 
haemorrhagic stroke, ischaemic stroke, road traffic injuries, falls, drowning, poisonings, self-
harm injuries, and interpersonal violence).  
We searched patients’ primary and secondary care records using relevant Read and ICD-10 
codes to identify patients with these morbidities. Where a patient had multiple consultations 
or hospital admissions with a specific code, only the earliest record was kept for this 
analysis. Multiple records of injuries were treated differently as injuries differ from chronic 
conditions whereby people can have multiple acute injuries over time. Instead of the earliest 
record, we kept records of all new injuries for our analysis. A new injury was defined as a 
diagnostic code entered 30days (for all injury types except fractures) or 100 days (for 
fractures) after an initial code for the same injury, for example if a patient had a first record of 
a fall and another record >30 days later, we kept both records as two different fall injuries. 
These time windows were chosen through examining of the distribution of medical codes 
after an initial injury event which showed that codes entered into the medical records due to 
repeat consultations for the same injury event levelled off around 30 days for most injures 
and around 90 days for fractures.  
Where patients had records of different morbidities entered on the same date, for example if 
an individual received a diagnosis code for hypertension and was also diagnosed with 
diabetes on the same date, both records of unique diseases were included. All alcohol 
related diseases were further categorised according to ICD chapter headings (malignant 
neoplasms, diabetes, diseases of the nervous system, cardiovascular diseases, digestive 
diseases, and injuries) for clarity of presentation. Injuries were categorised as either 
intentional (e.g. self-harm) or unintentional (e.g. falls), and where intent was not specified the 
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injury event was classed as unintentional. We defined four exposure periods prior to patients 
index date to assess morbidities: within 12 months of diagnosis, 13 months-2 years prior to 
diagnosis, 3-5 years prior to diagnosis and 6-10 years prior to diagnosis. 
 
Recording of alcohol consumption behaviour and related interventions 
All alcohol records within the CPRD database were extracted for each patient. These 
records are typically either numerical (units of alcohol consumed per week by a patient) or 
clinically coded (Read codes which reflect various levels of drinking or interventions). Using 
the highest drinking record derived for each patient based on the available unit or Read 
coded information, patient alcohol use was categorised into three levels: “never drinkers”, 
“moderate drinkers”, “harmful or hazardous drinkers”.  Our previous study (14) has shown 
that it is not always possible to assign an alcohol consumption category to all patients with 
alcohol records (those affected are usually patients with a record of an alcohol assessment 
test such as the AUDIT without any explicit consumption record). In such cases an ‘unclear’ 
consumption status was assigned. A separate category was created for those who had 
records of Read codes for alcohol brief intervention or alcohol related referrals irrespective of 
which drinking category they were in.   
 
 
Other covariates 
We extracted data on patient sex, age and smoking history from CPRD as potential 
confounders. Age was calculated as age at diagnosis of alcoholic psychosis (or at pseudo-
diagnosis for the population controls) and categorized into five age bands of 18–44, 45–54, 
55–64, 65–74 and ≥ 75 years. Smoking status was categorised as current smoker, ex-
smoker and non-smoker using the most recent smoking data recorded before a patient’s 
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diagnosis or pseudo-diagnosis date, and a 4th category “missing” was included for those 
without any smoking information. 
Statistical analysis 
Descriptive statistics were calculated for the study cohort and the control population. 
Healthcare utilisation was described at two levels; the overall healthcare utilisation rate for 
the study period and the yearly utilisation rate over the 10-year period before alcoholic 
psychosis diagnosis. The difference in utilisation rates between patients with alcoholic 
psychosis and the control population was estimated as the absolute difference in rates 
between both groups. Poisson regression models were used to generate rate ratios and 
95% Confidence Intervals (CI). Likelihood ratio tests were used to test for interaction 
between sex/or age and healthcare utilisation with the significance level defined at p<0.05. 
The prevalence of a specific morbidity was calculated as the number of patients ever 
diagnosed as the numerator and the number of patients with incident alcoholic psychosis or 
matched controls as denominator. Logistic regression was used to estimate Odds Ratios 
(ORs) for the association between alcoholic psychosis and each specific morbidity for the 
entire study period and for the four predefined exposure periods (within 12 months of 
diagnosis, 13 months-2 years prior to diagnosis, 3-5 years prior to diagnosis and 6-10 years 
prior to diagnosis). Only people considered to be at risk (based on length of follow-up) were 
considered to estimate the prevalence or OR’s in each study period.  Effect modification by 
age and sex was tested for via stratified analyses and the fitting of interaction terms in 
logistic regression models; the significance of models was tested using likelihood ratio tests 
(LRTs), with p<0.05 considered significant. 
To quantify the cases who had been previously given an alcohol assessment or alcohol 
intervention, numbers and proportions were calculated for each alcohol consumption 
category (‘never drinkers’, ‘moderate drinkers’ or ‘harmful/hazardous drinkers’) and for 
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patients with any record of a brief alcohol intervention/referral. All other patients without 
alcohol consumption, or intervention/referral records were labelled as ‘no data available’. 
Where possible, regression models were refitted applying the generalized estimating 
equation (GEE) approach with exchangeable correlation structure to test for heterogeneity 
within GP practices. 
All statistical analyses were conducted using Stata statistical software version 13.0 
(StataCorp Inc., College Station, TX, USA). 
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Results 
We included 1,731 patients with alcoholic psychosis and 17,310 matched control patients 
from 338 English GP practices (Table 1). The median observation time before diagnosis 
/pseudo-diagnosis was 5.5 years for the alcoholic psychosis cohort and 4.4 years for the 
control group. The mean (S.D) age at alcoholic psychosis diagnosis was 53.9 years (S.D 
17.3). Among patients with alcoholic psychosis, there were more men and more current 
smokers (Table 2). 
 
Healthcare utilisation 
During the study period, the rate of primary care consultation among alcoholic psychosis 
patients was approximately 10 consultations per year. This corresponded to a 53% higher 
consultation rate [Rate ratio 1.53, CI 1.52 to 1.54] or an average excess of 3 more 
consultations per year in patients with alcoholic psychosis compared to the control 
population.  The greatest excesses in primary care use were found in the years closest to 
alcoholic psychosis diagnosis (Table 3). Being male was associated with greater excesses in 
consulting with primary care when compared to the control population (P value for likelihood 
ratio test for sex interaction < 0.0001). No significant interaction was found between age and 
primary care consultation rates in people with alcoholic psychosis. 
Patterns of hospitalisation rates were also similar to that of primary care consultations. Pre-
diagnosis hospitalisations were more than two-fold greater in patients with alcoholic 
psychosis than in the control population (IRR 2.4, 95% CI 2.3-2.5) (Table 4). Again, though 
most marked in the years before diagnosis, the difference in hospitalisation rates was 
apparent as early as up to 8 years before the diagnosis of alcoholic psychosis. There was a 
slightly higher number of excess hospitalisations in men than women within three years 
before the diagnosis of alcoholic psychosis (Table 4), but earlier than that, the annual 
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excesses were higher in women (likelihood ratio test for interaction between sex and rates of 
admission p=0.04). 
Prior morbidities among patients 
A total of 66.8% of patients with alcoholic psychosis had presented with at least one alcohol 
attributable condition during a preceding primary care visit or hospitalisation, compared to 
33.2% of the control population (Table 5). A higher proportion of patients presented with 
alcohol-related conditions compared to alcohol-specific conditions (63.8% vs. 20.5%).  Due 
to insufficient numbers in many disease categories, results for each alcohol specific 
condition are not presented. Among the alcohol-related morbidities, all except malignant 
neoplasms were statistically significantly more prevalent in the alcoholic psychosis cohort. 
However, the most common were unintentional injuries (41.1%), intentional injuries (18.8%), 
cardiovascular diseases (22.9%) and epileptic seizures (7.7%). Epileptic seizures (OR 7.1, 
95%CI 5.6-9.0), unintentional injuries (OR 4.5, 95% CI 4.0-5.0) and intentional injuries (OR 
11.8, 95% CI 9.8-14.1) showed the strongest association with later diagnosis of alcoholic 
psychosis. The calculation of OR’s over time, showed that the association between injuries 
(unintentional and intentional), seizures and alcoholic psychosis persisted up to 10 years 
before diagnosis, while other disease associations did not(Figure 1). 
 
Alcohol records 
We found prior records of alcohol use status for 79.1% of patients with alcoholic psychosis 
and 65.4% of controls (Table 6). When stratified by levels of drinking, 50% of the alcoholic 
psychosis cohort had a harmful or hazardous drinking record prior to alcoholic psychosis 
diagnosis (Table 2). Analysis of the timing of records showed that most patients were 
recorded as heavy drinkers, on average, up to 5 years before the diagnosis of alcoholic 
psychosis. Men with alcoholic psychosis were more likely than women to have any alcohol 
consumption record [men adjusted OR 1.7, 95% CI 1.5-2.0; women adjusted OR 1.2, 95% 
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CI 0.9-1.5; likelihood ratio test P value for sex interaction= 0.0012) (Table 6). We found no 
significant difference in the prevalence of records across age-groups (Likelihood ratio test p 
value for age interaction 0.12). 
A much lower proportion of patients were found to have prior records of interventions. We 
found records of an alcohol brief intervention or alcohol related referrals to other services for 
1 in every 5 patients with alcoholic psychosis (Table 7). When results were stratified across 
age groups, significant differences were identified (likelihood ratio test p value for age 
interaction= 0.02) with records showing patients aged 18-44 years [OR 4.3 95%CI 3.1-5.8] 
were more likely to be offered alcohol brief interventions or referred on to other alcohol 
services compared to those who were older [OR for 45-54 years 3.2, 95% CI 2.2-4.8; OR for 
≥ 75 years 2.4, 95% CI 1.5-3.7] (Table 7). When results were stratified by sex, we found no 
difference between men and women (likelihood ratio test p value for sex interaction = 0.06).  
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Discussion 
Summary of main findings 
This study has shown that prior to alcoholic psychosis diagnosis, patients have a high 
healthcare utilisation, of around 50% increase per annum compared with an age, sex, and 
general practice-matched control population. This excess in healthcare utilisation may be 
explained by a higher prevalence of alcohol related morbidities in patients, as approximately 
two-thirds of patients were seen for such morbidities compared to 33% in the control 
population. Of all assessed alcohol related morbidities, seizures and injuries (both intentional 
and unintentional) were more strongly associated with a later development of alcoholic 
psychosis. Assessing injuries in slightly more detail suggested that falls, assaults and self-
harm were accountable for >80% of the injury burden among patients. 
In terms of how often alcohol assessments and interventions were offered to patients prior to 
alcoholic psychosis diagnosis, 79% of patients with alcoholic psychosis had previously had 
an alcohol assessment (based on records of alcohol status being available). However, it was 
only in 1 in 5 patients that interventions to reduce alcohol consumption were recorded. There 
were significant differences in alcohol records across subgroups such that men were more 
likely than women to have a record of their alcohol use in primary care, but not an alcohol 
related intervention. Younger age groups (18-44 years) were more likely to have records of 
interventions than those who were older. 
 
Strengths and limitations 
This is the first longitudinal study to comprehensively describe primary and secondary care 
use and alcohol-related morbidities among people who go on to develop alcoholic psychosis, 
compared with a representative general population control group, and therefore the first to 
provide insight into opportunities for earlier interventions. By using contemporary, nationally 
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representative data collected prospectively during routine clinical care, our findings are 
generalizable to most current patients in England with clinically diagnosed alcoholic 
psychosis. Although we have used only patients from half of the practices contributing to 
CPRD (as these are the only practices where secondary care records are linkable), it has 
been suggested this is unlikely to affect generalisability as patients from linked CPRD 
practices are reasonably similar in terms of age and sex to those from non-linkable practices 
(15). The large size of the dataset has allowed us to generate robust estimates of healthcare 
use and of the associations between alcoholic psychosis and alcohol related morbidities. We 
have also been able to minimise recall bias inherent to retrospective studies, by virtue of the 
prospective nature that data in CPRD are recorded. 
As with any study using routinely available data, an inherent potential weakness is the 
validity of the diagnostic data of each patient. CPRD has been previously validated for a 
wide range of diseases including psychosis, cardiovascular, digestive diseases and cancers. 
Validation studies on psychosis in primary care have however not focused specifically on the 
alcoholic psychosis subgroup (16). Although we do not believe there is any reason why the 
validity of this subgroup should be dissimilar from the rest of the psychosis population, we 
are still unable to assess nor guarantee the sensitivity of diagnostic codes such as 
“Korsakoff’s alcoholic psychosis” and this may be a potential source of diagnostic inaccuracy 
in our study. Another potential limitation is that by defining interventions based on 
information recorded within patient records, we may have underestimated the true rate at 
which practitioners intervene for heavy drinking in the UK as there may be cases where brief 
advice to cut down on drinking is provided but not recorded as an intervention. Nevertheless, 
this underestimation would not explain the differences we have identified between men and 
women and across age-groups as there is not likely to be a bias in operation leading to 
increased /decreased recording of information influenced by age and gender. Insofar as part 
of the rationale of this study is to provide information that would improve the identification 
and treatment of people who drink heavily, we see this potential for underestimation due to 
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lack of recording not as a study weakness, but rather as a pointer to a potential area for 
practitioners to address.  It is worth noting that we have not assessed for changes in rates of 
intervening over time, so we are unable to highlight any change/improvement that has 
happened in recent years. We also cannot rule out the possibility that some of the higher 
prevalence of comorbidity in the alcoholic psychosis group may be due to better case finding 
prompted by higher patient contact with health services. Nevertheless, in injuries and 
seizures specifically, presentation is rather acute which suggests that the high frequency is 
more likely to be explained by a true increase in disease burden rather than opportunistic 
diagnostic probing. Our data showed that falls, fractures, assault and self-harm account for 
>80% of the injury burden in the alcoholic psychosis cohort, nonetheless further work 
evaluating detailed dimensions of injury, such as mechanism, severity and location, may be 
useful to inform the development targeted interventions for patients.  
Comparison to previous literature 
In relation to previously published work, prior studies on healthcare use in people with 
clinically diagnosed alcoholic psychosis are scarce. However, our finding that there is a high 
burden of specific alcohol related comorbidities prior to alcoholic psychosis diagnosis is 
comparable to results in the study by Perala et al.  Although Perala et al’s study differs by 
not being population based, by assessing fewer comorbidities, and by selecting an alcohol 
dependent control population, they also found a higher rate of fractures [OR 5.13], epilepsy 
[OR 2.8] and arrhythmias [OR 3.43] among 38 cases of alcoholic psychosis compared to the 
control population (4).  
Although not directly comparable, our previously published papers on people with alcoholic 
cirrhosis also found a high rate of healthcare utilisation for alcohol related morbidities among 
patients. However, by contrast, we found much stronger association for injuries (OR 5.7 vs. 
4.0) and epileptic seizures (OR 7.1 vs 4.4) in people with psychosis than in alcoholic 
cirrhosis. 
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Our results on the provision of alcohol treatment are also in agreement with other 
population-based research and reviews which report that the frequency of intervening for 
alcohol use among practitioners is low both in the UK and internationally (17-22). The 
reasons for this low uptake have ranged from practitioner to resource factors including 
insufficient time during consultations, inadequate training whereby practitioners do not feel 
competent to deal with alcohol related issues, lack of skills and lack of financial support from 
government policy (23).  
Conclusions and implications 
Overall, in this study we have found a higher rate of health service usage, higher incidence 
of injuries and seizures, and low level of recorded alcohol related interventions prior to 
alcoholic psychosis which have significant implications for preventing the disease and for 
healthcare professionals who take care of these patients.  
Together, these findings support the need for practitioners to optimise the provision (and/or 
recording) of alcohol related advice and support in accordance with guidance from the 
National Alcohol strategy and the National Institute for Health and Care Excellence (NICE).  
Optimising recording and/or delivery of alcohol support would not only impact positively on 
patients at risk of alcoholic psychosis but is required to address concerns over the high level 
of avoidable alcohol related morbidity and mortality in the UK.  Failure to do so could be 
detrimental and have knock-on effects on individuals, their families and carers, and 
healthcare services, whereby hospital and mental health services increasingly see patients 
with illnesses that could have been averted at a much earlier stage.  
Based on the comorbidity results, perhaps, a closer review of people presenting with 
epileptic seizures and injuries (falls, fractures, assaults and self-harm) could be a more 
sensitive way of identifying harmful/hazardous drinkers that are more likely to develop 
alcoholic psychosis. When these patients are identified, evidence-based interventions can 
then be provided at an early stage when they are likely to be beneficial.  
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Table 2: Characteristics of people with alcoholic psychosis and controls. Figures are n(%) 
unless otherwise stated. 
  Cases Controls P value 
  n=1,731 n=17,310   
Age at diagnosis(years)    
Mean(SD) 53.3(17.3) 53.2(17.5)  
Age group (n, %)    
18-44 595(34.4) 5,999(34.7)  
45-54 334(19.3) 3,375(19.5)  
55-64 335(19.4) 3,170(18.3)  
65-74 236(13.6) 2,325(13.4)  
 ≥ 75 231(13.3) 2,441(14.1)  
Observation time(years)    
Median(IQR) 5.5(2.6-9.2) 4.4(2.3-8.2)  
   Up to 12months 1,731(100) 17,371(100)  
   Up to 2years 1,444(83.4) 13,789(79.7)  
   Up to 5years 912(52.7) 7,779(44.9)  
   Up to 10 years 362(20.9) 2,901(16.8)  
Sex (n, %)    
Male 1,156(66.8) 8,481(49.0)  
Female 575(33.2) 8,829(51.0)  
Smoking status   <0.001 
Non smoker 317(18.3) 7,089(40.9)  
Current smoker 875(50.6) 3,599(20.8) 
 
Ex-smoker 258(14.9) 2,953(17.1)  
Data not available 281(16.2) 3,669 (21.2)  
Level of Alcohol 
consumption as indicated 
in a patient's primary care 
record 
  <0.001 
Data available  1,369(79.1) 11,326(65.4)  
    Never drinker 54(3.1) 1,871(10.8) 
 
    moderate drinker 298(17.2) 7,316(42.3)  
    Hazardous/harmful drinker 881(50.8) 1,496(8.6)  
    unclear 136(7.9) 643(3.7)  
Data unavailable 362( 20.9 ) 5,984(34.6)  
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Table 3: Rates of primary care consultation and rate ratios comparing cases of alcoholic psychosis with the control population 
 
 
     
Males (Rate per person-years)              Females (Rate per person-years) 
 Cases Controls Excess IRR (95% CI) Cases Controls Excess IRR (95% CI) Cases Controls Excess IRR (95% CI) 
Overall 
study 
period 
 
9.9 6.5 3.4 1.53(1.52-1.54) 9.1 5.2 3.9 1.76(1.74-1.78) 11.5 7.7 3.8 1.49(1.48-1.51) 
Time to diagnosis(years) 
1 15.3 7.6 7.7 2.02(1.99-2.04) 14.4 6.1 8.3 2.35(2.31-2.39) 17.0 9.0 8.0 1.90(1.86-1.94) 
2 12.2 7.4 4.8 1.65(1.63-1.68) 11.2 6.0 5.2 1.86(1.82-1.89) 14.2 8.7 5.5 1.63(1.59-1.67) 
3 11.0 7.0 4.0 1.57(1.55-1.60) 10.1 5.7 4.4 1.77(1.73-1.81) 12.9 8.3 4.6 1.56(1.52-1.60) 
4 10.0 6.6 3.4 1.51(1.48-1.54) 9.2 5.3 3.9 1.74(1.69-1.78) 11.7 7.9 3.8 1.47(1.43-1.52)                                                                                                                                                        
5 9.5 6.3 3.2 1.49(1.46-1.52) 8.7 5.0 3.7 1.73(1.68-1.78) 11.0 7.6 3.4 1.44(1.39-1.49) 
6 7.9 6.0 1.9 1.31(1.27-1.34) 6.8 4.8 2.0 1.43(1.38-1.48) 10.1 7.2 2.9 1.39(1.34-1.45) 
7 7.4 5.7 1.7 1.31(1.27-1.35) 6.7 4.5 2.2 1.50(1.44-1.56) 8.9 6.8 2.1 1.30(1.25-1.36) 
8 6.6 5.4 1.2 1.22(1.18-1.26) 6.1 4.2 1.9 1.45(1.39-1.51) 7.7 6.6 1.1 1.17(1.11-1.23) 
9 6.2 5.0 1.2 1.23(1.19-1.28) 5.6 3.8 1.8 1.47(1.40-1.55) 7.4 6.2 1.2 1.20(1.13-1.27) 
10 5.3 4.8 0.5 1.11(1.06-1.16) 4.8 3.6 1.2 1.37(1.29-1.45) 6.3 5.9 0.4 1.06(0.99-1.14) 
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Table 4: Rates of hospitalisation and rate ratios comparing cases of alcoholic psychosis with the control population 
 
 
 
 
 
 
 
           Males (Rate per person-years)  Females (Rate per person-years) 
 Cases Controls Excess IRR (95% CI)     Cases Controls Excess IRR (95% CI) Cases Controls Excess IRR (95% CI) 
Overall 6.3 2.7 3.6 2.4(2.3-2.5) 6.4 2.6 3.8 2.5(2.4-2.6) 6.4 2.8 3.7 2.4(2.3-2.5) 
Time to 
diagnosis(years) 
            
1 14.4 3.5 10.9 4.1(3.9-4.3) 14.7 3.3 11.4 4.5(4.2-4.8) 13.9 3.8 10.1 3.7(3.4-4.0) 
2 8.3 3.1 5.2 2.7(2.5-2.8) 8.5 2.9 5.6 2.9(2.7-3.2) 7.8 3.3 4.5 2.4(2.1-2.6) 
3 6.4 2.9 3.5 2.2(2.0-2.3) 6.5 2.8 3.7 2.3(2.1-2.5) 6.1 3.1 3.0 2.0(1.8-2.3) 
4 5.4 2.6 2.8 2.1(1.9-2.2) 5.4 2.7 2.7 2.0(1.8-2.3) 5.4 2.6 2.8 2.1(1.8-2.4) 
5 4.9 2.4 2.5 2(1.8-2.2.0) 4.9 2.5 2.4 2.0(1.7-2.2) 5.0 2.4 2.6 2.1(1.8-2.4) 
6 4.1 2.3 1.8 1.8(1.6-2.0) 3.6 2.4 1.2 1.5(1.3-1.7) 5.0 2.2 2.8 2.3(1.9-2.7) 
7 3.5 2.3 1.2 1.5(1.3-1.7) 2.8 2.6 0.2 1.1(0.9-1.3) 4.8 2.1 2.7 2.3(1.9-2.8) 
8 3.3 2.1 1.2 1.6(1.3-1.8) 2.6 2.3 0.3 1.1(0.9-1.4) 4.8 1.9 2.9 2.5(2.0-3.1) 
9 2.6 2.0 0.6 1.3(1.1-1.6) 2.5 1.9 0.6 1.3(1.0-1.6) 2.8 2.0 0.8 1.4(1.0-1.9) 
10 2.3 1.6 0.7 1.4(1.1-1.7) 2.3 1.6 0.7 1.5(1.1-1.9) 2.2 1.7 0.5 1.3(0.9-1.9) 
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Table 5: Prevalence of alcohol attributable comorbidities  
 
 
 
  
 
Cases 
(n=1,731) 
   Controls    
(n=17,310) 
   OR (95% CI) 
     Model 1* 
 OR (95% CI) 
 Model 2**  
n (%) n (%)           
Overall numbers presenting with: 
  
  
Any alcohol attributable disease 
 
 
 
1,157(66.8) 
 
 
 
574(33.2) 
 
 
At least one alcohol-specific disease 354(20.5) 75(0.4)   
          At least one alcohol-related disease  1,104(63.8) 5,376(31.1) 3.9(3.5-4.3)  
Malignant neoplasms 27(1.6) 230(1.3) 1.2(0.8-1.8) 1.4(0.9-2.1) 
Diabetes 127 (7.3) 923 (5.3) 1.4(1.2-1.7) 1.3(1.1-1.7) 
Epileptic seizures 134 (7.7) 201(1.2) 7.1(5.7-8.9) 7.1(5.6-9.0) 
Cardiovascular diseases 396(22.9) 2,697(15.6) 1.6(1.4 -1.8) 1.7(1.5-1.9) 
Digestive diseases 72(4.2) 253(1.5) 2.9(2.2-3.8) 3.2(2.4-4.2) 
Unintentional injuries  712(41.1) 2,381(13.8) 4.4(3.9-4.9) 4.5(4.0-5.0) 
Intentional injury/self-harm 
 
   326(18.8) 290(1.7)  13.6(11.5-16.1) 11.8(9.8-14.1) 
Model  1*: Unadjusted Odds ratio    Model 2**: Adjusted for age, sex and smoking status 
n/b: Results for each alcohol specific disease have not been presented as too many cells have less than 5 people. 
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Table 6: Proportion and OR (95%CIs) of patients with alcohol use records stratified by sex and age  
 
Overall 
  
  Males 
  
 Females 
  
 
Cases  Controls  OR (95% CI) Cases Controls OR (95% CI) Cases Controls OR (95% CI) 
 
n=1,731 n=17,310 
 
n=1,156 n=8,481 
 
n= 575 n=8,829 
 
Overall 1,369(79.1) 11,326(65.4) 1.5(1.3-1.7)a 928(80.3) 5,307(62.6) 1.7(1.5-2.0)b 441(76.7) 6,019(68.2) 1.2(0.9-1.5)b 
Age at diagnosis 
         
   18-44 437(73.4) 3718(61.9) 1.8(1.5-2.3) 307(74.3) 1704(55.9) 2.3(1.8-2.8) 130(71.4) 2014(68.3) 1.2(0.9-1.7) 
   45-54 274(82.0) 2239(66.3) 2.5(1.9-3.3) 181(81.9) 1112(64.1) 2.6(1.9-3.6) 93(82.3) 1127(68.8) 2.1(1.4-3.4) 
   55-64 287(85.7) 2137(67.4) 2.9(2.2-4.2) 206(86.2) 1051(65.6) 3.5(2.3-5.2) 81(84.3) 1086(69.3) 2.3(1.2-4.2) 
   65-74 188(79.7) 1608(69.2) 1.7(1.2-2.5) 125(83.3) 768(67.5) 2.2(1.4-3.5) 63(73.3) 840(70.8) 1.2(0.7-2.1) 
   ≥ 75 183(79.2) 1624(66.5) 1.9(1.3-2.7) 109(82.0) 672(70.4) 2.1(1.3-3.4) 74(75.5) 952(64.0) 1.6(1.0-2.7) 
aOR adjusted for age, sex and consulting rate of patients 
     
bOR adjusted for age and consulting rate of patients   
     
lrtest for sex interaction: 0.0012;   test for age interaction: 0.12 
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Table 7: Proportion and OR (95% CIs) of patients with any alcohol intervention record, stratified by age. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cases  Controls  OR (95% CI)a 
 
n=1,731 n=17,310 
  
Overall 340(19.6) 908(5.3) 3.7(2.9-4.6)b 
Age at diagnosis 
    
   18-44 109(18.3) 228(3.8) 4.3(3.1-5.8) 
   45-54 76(22.8) 198(5.9) 3.2(2.2-4.8) 
   55-64 72(21.5) 185(5.8) 3.7(2.7-5.2) 
   65-74 63(26.7) 167(7.2) 3.8(2.7-5.2) 
   ≥ 75 30(12.9) 130(5.3) 2.4(1.5-3.7) 
aOR adjusted for sex and consulting rate unless otherwise stated  badjusted for age, sex and 
consulting rate; LRT for sex interaction P value: 0.06; LRT for age interaction P value 0.02 
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Figure 1: Odds ratios for the association between each morbidity and alcoholic psychosis versus the control population at each time period, 
adjusted for age, sex and smoking status.  Point estimates are shown in the data label below. 
 
 
